Tag: Prescription Drugs

Rifaximin monotherapy reduces risk for breakthrough OHE episode and results in a lower mortality rate than lactulose monotherapy

Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression

Second study shows that only 14 percent of patients correctly identified symptoms requiring epinephrine

Reduction of 75 and 77 percent seen in estimated mean monthly attack rate with 25-mg, 50-mg NTLA-2002 versus placebo

Corneal toxicity not uncommon with MIRV treatment for primary gynecologic malignancies, usually resolves

Barriers include access to treatment, insurance barriers, and financial issues

Adding 75-mg vial size would achieve greatest reduction in waste, representing annual savings of $99 million

People with a high number of antiseizure medications seem to be at risk for accelerated neuroaxonal loss

More than three-quarters of prescriptions were for a supply of more than seven days; 55 percent for 15 to 30 days

Prescriptions for GLP-1 RAs less common among White teens versus Black, Hispanic teens